ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674913 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674913; 2) Community: the network communities that were significantly associated with the response to NSC 674913; 3) Molecule: the relationships between components within communities and NSC 674913; 4) MDR: the compounds that were significantly associated with the NSC 674913.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.00707875925191925 0.35259213
NSC 357680 BUELLOLIDE 0.00707875925191925 0.43803785
NSC 404027 Null 0.00707875925191925 0.36351452
NSC 626167 Aplidazole C . TFA 0.00707875925191925 0.33689965
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.00707875925191925 0.61149359
NSC 658229 Null 0.00707875925191925 0.230784
NSC 672437 Null 0.00707875925191925 0.067779386
NSC 673841 1H-Dipyrazolo[1,5-a:4',3'-e]pyrimidine-3,4,7-triamine, 6-[(4-bromophenyl)azo]- 0.00707875925191925 0.26331523
NSC 712572 1,2 Benzo-8-(1-hydroxy-2-methylamino propane)-3-phenoxazone 0.00838963112864928 0.091345873
NSC 716535 Null 0.00838963112864928 0.35712992
Total:151  Current:45    [First] [Prev] [Next] [Last]